Skip to main content
Journal cover image

Surgical Outcomes in Patients with High Spinal Instability Neoplasm Score Secondary to Spinal Giant Cell Tumors

Publication ,  Journal Article
Elder, BD; Sankey, EW; Goodwin, CR; Kosztowski, TA; Lo, SFL; Bydon, A; Wolinsky, JP; Gokaslan, ZL; Witham, TF; Sciubba, DM
Published in: Global Spine Journal
March 26, 2015

Study Design Retrospective review. Objective To describe the surgical outcomes in patients with high preoperative Spinal Instability Neoplastic Score (SINS) secondary to spinal giant cell tumors (GCT) and evaluate the impact of en bloc versus intralesional resection and preoperative embolization on postoperative outcomes. Methods A retrospective analysis was performed on 14 patients with GCTs of the spine who underwent surgical treatment prior to the use of denosumab. A univariate analysis was performed comparing the patient demographics, perioperative characteristics, and surgical outcomes between patients who underwent en bloc marginal (n = 6) compared with those who had intralesional (n = 8) resection. Results Six patients underwent en bloc resections and eight underwent intralesional resection. Preoperative embolization was performed in eight patients. All patients were alive at last follow-up, with a mean follow-up length of 43 months. Patients who underwent en bloc resection had longer average operative times (p = 0.0251), higher rates of early (p = 0.0182) and late (p = 0.0389) complications, and a higher rate of surgical revision (p = 0.0120). There was a 25% (2/8 patients) local recurrence rate for intralesional resection and a 0% (0/6 patients) local recurrence rate for en bloc resection (p = 0.0929). Conclusions Surgical excision of spinal GCTs causing significant instability, assessed by SINS, is associated with high intraoperative blood loss despite embolization and independent of resection method. En bloc resection requires a longer operative duration and is associated with a higher risk of complications when compared with intralesional resection. However, the increased morbidity associated with en bloc resection may be justified as it may minimize the risk of local recurrence.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Global Spine Journal

DOI

EISSN

2192-5690

ISSN

2192-5682

Publication Date

March 26, 2015

Volume

6

Issue

1

Start / End Page

21 / 28

Related Subject Headings

  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Elder, B. D., Sankey, E. W., Goodwin, C. R., Kosztowski, T. A., Lo, S. F. L., Bydon, A., … Sciubba, D. M. (2015). Surgical Outcomes in Patients with High Spinal Instability Neoplasm Score Secondary to Spinal Giant Cell Tumors. Global Spine Journal, 6(1), 21–28. https://doi.org/10.1055/s-0035-1555657
Elder, B. D., E. W. Sankey, C. R. Goodwin, T. A. Kosztowski, S. F. L. Lo, A. Bydon, J. P. Wolinsky, Z. L. Gokaslan, T. F. Witham, and D. M. Sciubba. “Surgical Outcomes in Patients with High Spinal Instability Neoplasm Score Secondary to Spinal Giant Cell Tumors.” Global Spine Journal 6, no. 1 (March 26, 2015): 21–28. https://doi.org/10.1055/s-0035-1555657.
Elder BD, Sankey EW, Goodwin CR, Kosztowski TA, Lo SFL, Bydon A, et al. Surgical Outcomes in Patients with High Spinal Instability Neoplasm Score Secondary to Spinal Giant Cell Tumors. Global Spine Journal. 2015 Mar 26;6(1):21–8.
Elder, B. D., et al. “Surgical Outcomes in Patients with High Spinal Instability Neoplasm Score Secondary to Spinal Giant Cell Tumors.” Global Spine Journal, vol. 6, no. 1, Mar. 2015, pp. 21–28. Scopus, doi:10.1055/s-0035-1555657.
Elder BD, Sankey EW, Goodwin CR, Kosztowski TA, Lo SFL, Bydon A, Wolinsky JP, Gokaslan ZL, Witham TF, Sciubba DM. Surgical Outcomes in Patients with High Spinal Instability Neoplasm Score Secondary to Spinal Giant Cell Tumors. Global Spine Journal. 2015 Mar 26;6(1):21–28.
Journal cover image

Published In

Global Spine Journal

DOI

EISSN

2192-5690

ISSN

2192-5682

Publication Date

March 26, 2015

Volume

6

Issue

1

Start / End Page

21 / 28

Related Subject Headings

  • 3202 Clinical sciences